Abstract: A spur gear of a gearbox of a gas turbine engine system of an aircraft includes a gear body, and a plurality of gear teeth extending radially outwardly from the gear body. A gear tooth of the plurality of gear teeth includes two opposing tooth sides extending to a tooth tip. The tooth tip defines a radially outboard extent of the gear tooth. A first tooth side of the opposing tooth sides has a first pressure angle, and a second tooth side of the opposing tooth sides has a second pressure angle different from the first pressure angle.

Abstract: The present disclosure provides systems and methods for controlling a welding machine comprising an electrode lead and a workpiece lead connectible to one of a plurality of welding platforms. An example method comprises determining if the workpiece lead is connected to a desired welding platform mounting a workpiece to be welded, and only applying a welding current to the electrode lead when the workpiece lead is connected to the desired welding platform. Determining if the workpiece lead is connected to the desired welding platform may comprise applying a probing current to the electrode lead and contacting the electrode lead to a workpiece mounted on one of the plurality of welding platforms, and monitoring current through ground connections of the welding platforms and determining that the workpiece lead is connected to the desired welding platform if less than a threshold current level is detected flowing through any ground connection.

Abstract: Disclosed is a system having a robotic welding apparatus configured to weld metal sections together along a seam, an input device configured to produce positioning input for the robotic welding apparatus while welding, and a controller configured to control the robotic welding apparatus in accordance with (i) a recording state in which operation of the robotic welding apparatus is controlled and recorded while welding in a root pass based on the positioning input to produce recorded positioning data, and (ii) an automatic state in which operation of the robotic welding apparatus is automatically controlled while welding in a subsequent pass based on the recorded positioning data. In accordance with an embodiment, motion of the robotic welding apparatus is selectively recorded such that the recorded positioning data utilized in the automatic state omits (i) initial transient motions of the robotic welding apparatus and/or (ii) stop-start motions of the robotic welding apparatus.

Abstract: A spline coupling comprises a male spline member having male spline teeth and a female spline member having female spline teeth complementary to and engaged with the male spline teeth. One or more of the female spline teeth has a tooth height lesser than a tooth height of another one or more of the female spline teeth. The tooth height of the one or more of the female spline teeth is defined by a top land surface of the one or more of the female spline teeth. The tooth height of the other one or more of the female spline teeth is defined by a top land surface of the other one or more of the female spline teeth. A drainage hole in the top land surface of the one or more of the female spline teeth passes through the one or more of the female spline teeth.

Abstract: A spline coupling comprises a male spline member having male spline teeth and a female spline member having female spline teeth complementary to and engaged with the male spline teeth. One or more of the female spline teeth has a tooth height lesser than a tooth height of another one or more of the female spline teeth. The tooth height of the one or more of the female spline teeth is defined by a top land surface of the one or more of the female spline teeth. The tooth height of the other one or more of the female spline teeth is defined by a top land surface of the other one or more of the female spline teeth. A drainage hole in the top land surface of the one or more of the female spline teeth passes through the one or more of the female spline teeth.

Abstract: This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae I and III-XII, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae I and III-XII.

Abstract: A sensor adaptor circuit housing assembly and method of manufacturing includes a circuit board, a housing, an input wire, and a connector. The circuit board includes an electrical circuit configured for receiving a sensor signal and generating a sensor characteristic in response to the received sensor signal. The housing includes a body and a cavity defined by inner surfaces of the body and adapted for receiving the circuit board, the circuit board being positioned within the cavity. The input wire is configured for receiving the signal from a sensor and can be formed with an insulated solid or stranded conductor. The connector includes a unitary body, a first end of the unitary body attached directly to an end of the input wire, a second end of the unitary body positioned within the cavity and attached directly to the circuit board and making a first electrical connection with the electrical circuit.

Abstract: A temperature sensor assembly and method of manufacturing thereof having a temperature probe, a mounting connector, a wire set, a transition component, a housing, and a circuit is provided. The temperature probe includes a probe body, a temperature sensor and at least one conductor configured for providing a temperature signal indicative of a temperature over the at least one conductor. The circuit is enclosed within the housing and configured for receiving the temperature signal from the temperature probe and generating the temperature characteristic in response to the received temperature signal.

Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): wherein W, V, x, y, R1, R2, R3, R4, R5, R6, R7, R7a, R8, R8a, R9, R9a, R10 and R10a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (1): wherein: W is —O—, —N(R1)—, C(O), S(O)t ; (where t is 0, 1 or 2), N(R1)S(O)2, S(O)2N(R1) , C(O)N(R1) or N(R1)C(O)N(R1); and V is C(O), C(S), C(O)N(R1)—, C(O)O—, S(O)2—, S(O)2N(R1)— or C(R1)H; and x, y, R1, R2, R3, R4, R5, R6, R7, R7a, R8, R8a, R9, R9a, R10 and R10a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.

Abstract: In an online system a passenger enters a trip, seeking an individual seat on a charter aircraft. Available charter operators and aircraft are selected from a database using scheduling and pricing algorithms to match the passenger's request to existing flights and newly created flights. The charter operator is alerted to the passenger request and requested to confirm their acceptance of the passenger's trip. The passenger receives a confirmation and a quote for the trip. The passenger is able to realize many of the benefits of charter travel at substantially lower prices.

Abstract: This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation, preferably in a reversible manner. The compounds useful for this invention include compounds of general Formulae I and III-XII, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds of Formulae I and III-XII.

Abstract: This invention is directed to a method of preventing or treating diseases or conditions associated with platelet aggregation. The method is also directed to a method of treating thrombosis or related disorders. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a non-nucleotide compound, preferably a P2Y12 receptor antagonist compound, wherein said amount is effective to inhibit platelet aggregation. The compounds useful for this invention include compounds of general Formulae I and III-XI, or salts, hydrates, and solvates thereof. The present invention also provides novel compounds according to Formulae I and III-XI.

Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where m, n, p, V, R1, R2, R3, R4, R5 and R6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.